Cargando…

Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent

OBJECTIVES: The aim of this study was to characterize the cardiovascular disease (CVD) profile and describe the incidence and characteristics of cardiovascular (CV) events in patients with esophageal cancer (EC) following chemoradiation and surgery. BACKGROUND: Underlying CVD is a concern in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Søndergaard, Mette Marie A., Nordsmark, Marianne, Nielsen, Kirsten M., Poulsen, Steen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702793/ https://www.ncbi.nlm.nih.gov/pubmed/34988480 http://dx.doi.org/10.1016/j.jaccao.2021.10.002

Ejemplares similares

Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma
por: Kandilis, Apostolos, et al.
Publicado: (2020)

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent
por: Haj Mohammad, N., et al.
Publicado: (2015)

Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
por: Park, Jun Chul, et al.
Publicado: (2009)

Surgical treatment of esophageal carcinoma with curative intent: analysis of a single center experience
por: De Giacomo, Tiziano, et al.
Publicado: (2013)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015)

Neoadjuvant Concurrent Chemoradiation for Curative Treatment of Penile Squamous Cell Carcinoma
por: Chhabra, Arpit, et al.
Publicado: (2014)

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
por: Yegya-Raman, Nikhil, et al.
Publicado: (2019)

Mucocutaneous Adverse Reactions of Cancer Chemotherapy and Chemoradiation
por: Naveed, Sheikh, et al.
Publicado: (2019)

The Importance of Reference Gene Analysis of Formalin-Fixed, Paraffin-Embedded Samples from Sarcoma Patients — An Often Underestimated Problem()()
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2014)

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2019)

A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy
por: Yamada, Kaori, et al.
Publicado: (2018)

Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma
por: Deng, Wei, et al.
Publicado: (2020)

Concurrent Chemoradiation for Mediastinal Oligometastases From Cervical Cancer: A Potentially Curative Treatment
por: Bonilla, Carlos E, et al.
Publicado: (2020)

Methodology for computing the burden of disease of adverse events following immunization
por: McDonald, Scott A., et al.
Publicado: (2018)

Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events
por: Mani, Venkatesh, et al.
Publicado: (2009)

Feasibility of Concurrent Chemoradiation in Patients treated for Esophageal Carcinoma: A Single Institutional Experience
por: Kannan, Ram Abhinav
Publicado: (2014)

Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2017)

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients
por: Warnecke-Eberz, Ute, et al.
Publicado: (2020)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients
por: Yang, Junjie, et al.
Publicado: (2019)

Rectal cancer treatment and outcomes in elderly patients treated with curative intent
por: Kang, Sharlyn, et al.
Publicado: (2021)

The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer
por: Wang, Xin, et al.
Publicado: (2022)

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events
por: Hehir, Michael K., et al.
Publicado: (2022)

Adjuvant Immunotherapy in Curative Intent Esophageal Cancer Resection Patients: Real-World Experience within an Integrated Health System
por: Kwak, Hyunjee V., et al.
Publicado: (2023)

A curated and standardized adverse drug event resource to accelerate drug safety research
por: Banda, Juan M., et al.
Publicado: (2016)

Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study
por: Kang, Danbee, et al.
Publicado: (2023)

Cardiomyocyte-specific circulating cell-free methylated DNA in esophageal cancer patients treated with chemoradiation
por: Roth, Sarah Martinez, et al.
Publicado: (2021)

Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer
por: Winther, Mette, et al.
Publicado: (2016)

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
por: Haj Mohammad, Nadia, et al.
Publicado: (2014)

Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2021)

Curative-Intent Treatment with Durvalumab in Early-Stage Cancers
por: Melillo, Giovanni, et al.
Publicado: (2021)

Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab
por: Ngo, Doan T. M., et al.
Publicado: (2020)

Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients
por: Zhao, Lina, et al.
Publicado: (2017)

Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
por: Triantafyllou, Tania, et al.
Publicado: (2020)

A Case Report of an Early Response to Definitive Chemoradiation for Esophageal Carcinoma Cuniculatum
por: Long, David E., et al.
Publicado: (2020)

Tumor‐immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas
por: Soeratram, Tanya TD, et al.
Publicado: (2021)

Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations
por: Nordsmark, M, et al.
Publicado: (2001)

Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy
por: Chou, Wen-Chi, et al.
Publicado: (2022)

Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma
por: Geers, Joachim, et al.
Publicado: (2020)

Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
por: Zane, Kylie E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_091sdbo1drrg5q0unhklb81586